This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA339061; GEO: GSE85688 |
| Type | Umbrella project |
| Publications | Rokavec M et al., "Cellular Model of Colon Cancer Progression Reveals Signatures of mRNAs, miRNA, lncRNAs, and Epigenetic Modifications Associated with Metastasis.", Cancer Res, 2017 Apr 15;77(8):1854-1867 |
| Submission | Registration date: 16-Aug-2016 Hermeking, Institute of Pathology, Ludwig-Maximilians-University Munich |
| Relevance | Superseries |
Project Data:
| Resource Name | Number of Links |
|---|
| Sequence data |
| SRA Experiments | 16 |
| Publications |
| PubMed | 1 |
| Other datasets |
| BioSample | 16 |
| GEO DataSets | 5 |
GEO Data Details| Parameter | Value |
|---|
| Data volume, Spots | 2001248 |
| Data volume, Processed Mbytes | 59 |
| Data volume, Supplementary Mbytes | 73 |
SRA Data Details| Parameter | Value |
|---|
| Data volume, Gbases | 28 |
| Data volume, Mbytes | 16402 |
Cellular model of colon cancer progression reveals signatures of mRNAs, miRNA, lncRNAs and epigenetic modifications associated with metastasis. encompasses the following 4 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 2 |
BioProject accession | Organism | Title |
|---|
| PRJNA338751 | Homo sapiens | DNA methylation profiling of four DLD1 colorectal cancer cell derivatives that recapitulate EMT/MET transitions during metastasis. (Hermeking, Institute of Pathology,...) | | PRJNA339293 | Homo sapiens | Cellular model of colon cancer progression reveals signatures of mRNAs, miRNA, lncRNAs and epigenetic modifications associated with metastasis. (Hermeking, Institute of Pathology,...) |
|
| Transcriptome or Gene expression | 2 |
BioProject accession | Organism | Title |
|---|
| PRJNA339109 | Homo sapiens | microRNA profiling of four DLD1 colorectal cancer cell derivatives that recapitulate EMT/MET transitions during metastasis. (Hermeking, Institute of Pathology,...) | | PRJNA339111 | Homo sapiens | RNA profiling of four DLD1 colorectal cancer cell derivatives that recapitulate EMT/MET transitions during metastasis. (Hermeking, Institute of Pathology,...) |
|